BlackRock Finance, Inc.

Filing Details

13F-HR2024-06-30
Report Date
2024-06-30
Filing Date
2024-08-13
Total Holdings
47,163
Total Value
3836793075164
Accession Number
0001086364-24-008417
Form Type
13F-HR
Manager Name
BlackRock Finance, Inc.
Data Enrichment
92% identified
43,337 identified3,826 unidentified

Holdings

47,163 positions
Manager:
Search and click to pin securities to the top
Page 226 of 262
TherapeuticsMD, Inc.
Shares:
125152(-7.8%)
Value:
$201.5M(-35.2%)
New Found Gold Corp.
Shares:
71068(+0.0%)
Value:
$201.1M(-23.5%)
Bolt Biotherapeutics, Inc.
Shares:
267068(+4.7%)
Value:
$200.3M(-43.9%)
SurgePays, Inc.
Shares:
62482(+23.9%)
Value:
$199.3M(+2.6%)
G5391L110
Shares:
494750(-0.1%)
Value:
$197.9M(-20.2%)
62526P406
Shares:
82228(+17.0%)
Value:
$197.3M(-46.0%)
Crexendo, Inc.
Shares:
62452(+2.5%)
Value:
$196.4M(-33.0%)
Benitec Biopharma Inc.
Shares:
28004
Value:
$195.7M
FIRST NATIONAL CORP /VA/
Shares:
12838(+4.4%)
Value:
$195.0M(-2.5%)
First Guaranty Bancshares, Inc.
Shares:
21655(+3.1%)
Value:
$194.9M(-8.6%)
LISATA THERAPEUTICS, INC.
Shares:
56013(+0.0%)
Value:
$194.4M(+11.2%)
CAMTEK LTD
Shares:
1544(+148.6%)
Value:
$193.4M(+271.7%)
140755109
Shares:
744707(-78.2%)
Value:
$192.1M(-93.8%)
A.K.A. BRANDS HOLDING CORP.
Shares:
12433(+883.6%)
Value:
$189.6M(+1409.1%)
PIONEER POWER SOLUTIONS, INC.
Shares:
47685(+2.9%)
Value:
$189.3M(-28.5%)
Adaptimmune Therapeutics PLC
Shares:
193757(-33.1%)
Value:
$188.9M(-58.7%)
Fortress Biotech, Inc.
Shares:
109957(+46.7%)
Value:
$188.0M(+25.4%)
46434V100
Shares:
3786(+0.9%)
Value:
$186.5M(+1.0%)
Lantern Pharma Inc.
Shares:
39841(+102.7%)
Value:
$186.1M(+7.5%)
AMARIN CORP PLC\UK
Shares:
270064(+8.2%)
Value:
$185.8M(-16.5%)